ENACT (Expanding Nilotinib Access in Clinical Trials) study in adult patients (pts) with Imatinib-resistant or -intolerant Chronic Myeloid Leukemia (CML): Subgroup analysis of Pts from Germany, Austria and Switzerland (DACH)
- HK Al-Ali (Author)
- P le Coutre (Author)
- J Duyster (Author)
- Werner Linkesch (Author)
- D Wolf (Author)
- U Schanz (Author)
- GM Baerlocher (Author)
- B Wackwitz (Author)
- D Heim (Author)
Activity: Talk, presentation or poster › Poster